Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefèbvre JL. Bernier J, et al. Among authors: van glabbeke m. Head Neck. 2005 Oct;27(10):843-50. doi: 10.1002/hed.20279. Head Neck. 2005. PMID: 16161069
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.
Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M; European Organization for Research and Treatment of Cancer Trial 22931. Bernier J, et al. Among authors: van glabbeke m. N Engl J Med. 2004 May 6;350(19):1945-52. doi: 10.1056/NEJMoa032641. N Engl J Med. 2004. PMID: 15128894 Free article. Clinical Trial.
ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
Bernier J, Denekamp J, Rojas A, Minatel E, Horiot J, Hamers H, Antognoni P, Dahl O, Richaud P, van Glabbeke M, Piérart M. Bernier J, et al. Among authors: van glabbeke m. Radiother Oncol. 2000 May;55(2):111-9. doi: 10.1016/s0167-8140(00)00165-1. Radiother Oncol. 2000. PMID: 10799722 Clinical Trial.
European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey.
Horiot JC, van den Bogaert W, Ang KK, Van der Schueren E, Bartelink H, Gonzalez D, de Pauw M, van Glabbeke M. Horiot JC, et al. Among authors: van glabbeke m, van der schueren e, van den bogaert w. Front Radiat Ther Oncol. 1988;22:149-61. doi: 10.1159/000415105. Front Radiat Ther Oncol. 1988. PMID: 3280411 Review. No abstract available.
[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice].
Horiot JC, Bontemps P, Begg AC, Le Fur R, Van den Bogaert W, Bolla M, N'Guyen T, Van den Weijngaert D, Bernier J, Lusinchi A, Stuschke D, Lopez Torrecilla D, Jancar B, Collette L, Van Glabbeke M, Pierart M. Horiot JC, et al. Among authors: van glabbeke m, van den bogaert w, van den weijngaert d. Bull Cancer Radiother. 1996;83(4):314-20. Bull Cancer Radiother. 1996. PMID: 9081333 Clinical Trial. French. No abstract available.
Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group.
Jassem J, Karnicka-Młodkowska H, van Pottelsberghe C, van Glabbeke M, Noseda MA, Ardizzoni A, Gozzelino F, Planting A, van Zandwijk N. Jassem J, et al. Among authors: van glabbeke m, van pottelsberghe c, van zandwijk n. Eur J Cancer. 1993;29A(12):1720-2. doi: 10.1016/0959-8049(93)90112-s. Eur J Cancer. 1993. PMID: 8398301 Clinical Trial.
Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
Miralbell R, Mornex F, Greiner R, Bolla M, Storme G, Hulshof M, Bernier J, Denekamp J, Rojas AM, Pierart M, van Glabbeke M, Mirimanoff RO. Miralbell R, et al. Among authors: van glabbeke m. J Clin Oncol. 1999 Oct;17(10):3143-9. doi: 10.1200/JCO.1999.17.10.3143. J Clin Oncol. 1999. PMID: 10506611 Clinical Trial.
Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis.
Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S, Pierart M, Van Glabbeke M. Karim AB, et al. Among authors: van glabbeke m. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):316-24. doi: 10.1016/s0360-3016(01)02692-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872276 Clinical Trial.
The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas.
Abele R, Clavel M, Dodion P, Bruntsch U, Gundersen S, Smyth J, Renard J, van Glabbeke M, Pinedo HM. Abele R, et al. Among authors: van glabbeke m. Eur J Cancer Clin Oncol. 1987 Dec;23(12):1921-4. doi: 10.1016/0277-5379(87)90060-5. Eur J Cancer Clin Oncol. 1987. PMID: 2449354 Clinical Trial.
164 results